Vaccine victory: Novavax jab reports 96% efficacy in UK trial – Hancock orders 60m doses

THE Novavax vaccine has been found to be 96 percent effective against the original coronavirus strain in a UK trial – as well as being 100 percent effective in preventing serious illness and death.
Daily Express :: News Feed

LEAVE A REPLY

Please enter your comment!
Please enter your name here